Cargando…
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
BACKGROUND: Chondrosarcoma is the second most common primary sarcoma of bone. High-grade conventional chondrosarcoma and dedifferentiated chondrosarcoma have a poor outcome. In pre-clinical research aiming at the identification of novel treatment targets, the need for representative cell lines and m...
Autores principales: | van Oosterwijk, Jolieke G, de Jong, Danielle, van Ruler, Maayke AJH, Hogendoorn, Pancras CW, Dijkstra, PD Sander, van Rijswijk, Carla SP, Machado, Isidro, Llombart-Bosch, Antonio, Szuhai, Karoly, Bovée, Judith VMG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484068/ https://www.ncbi.nlm.nih.gov/pubmed/22928481 http://dx.doi.org/10.1186/1471-2407-12-375 |
Ejemplares similares
-
Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011) -
BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors
por: Boeuf, Stephane, et al.
Publicado: (2012) -
The molecular pathogenesis of dedifferentiated chondrosarcoma
por: Sakamoto, Akio
Publicado: (2014) -
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009) -
Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation
por: de Andrea, Carlos E., et al.
Publicado: (2011)